Financials
- Market Capitalization 2.37 B
- Employee 540
- Founded 2008
- CEO N/A
- Website www.agios.com
- Headquarter Delaware, United States
- FIGI BBG000QY4ZD0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1873 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 56.11 USD | -5.40% | -20.06% | -9.69% | -15.06% | 2.41 B USD | ||
| 1880 | NRIX Nurix Therapeutics, Inc. - Common stock | 22.98 USD | +1.19% | -4.29% | +35.74% | +105.00% | 2.38 B USD | ||
| 1888 | VCEL Vericel Corporation - Common Stock | 46.09 USD | -2.95% | -1.20% | +19.96% | +26.80% | 2.35 B USD | ||
| 1901 | NKTR Nektar Therapeutics - Common Stock | 67.17 USD | -1.68% | -9.23% | +10.19% | -8.33% | 2.27 B USD |
Frequently asked questions about Agios Pharmaceuticals, Inc. - Common Stock
What is the Agios Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Agios Pharmaceuticals, Inc. - Common Stock (AGIO) is 39.92. Over the past 24 hours, the stock has changed by -1.55%. Follow the AGIO chart for real-time price dynamics.
What is the stock ticker of Agios Pharmaceuticals, Inc. - Common Stock?
Agios Pharmaceuticals, Inc. - Common Stock trades under the ticker AGIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Agios Pharmaceuticals, Inc. - Common Stock stock going up?
AGIO has changed by -8.78% over the last week, +24.83% over the last month, and -8.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Agios Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Agios Pharmaceuticals, Inc. - Common Stock reported net income of -99.11 M for the last quarter. The previous quarter showed -108.04 M, which means net income changed by +8.26%.
How many employees does Agios Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Agios Pharmaceuticals, Inc. - Common Stock has 540 employees. Workforce size can provide additional context about the company's scale and operations.
What is Agios Pharmaceuticals, Inc. - Common Stock EBITDA?
Agios Pharmaceuticals, Inc. - Common Stock EBITDA is -109.81 M, and its EBITDA margin is -529.29%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Agios Pharmaceuticals, Inc. - Common Stock stock?
You can buy Agios Pharmaceuticals, Inc. - Common Stock (AGIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Agios Pharmaceuticals, Inc. - Common Stock stock?
Investing in Agios Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AGIO chart and related analysis on metatrader.com as part of your research.